Expert interpretation: Judge the clinical selection of tiotropium bromide from three angles!

At present, the prevention and treatment situation of chronic obstructive pulmonary disease in the world is serious.As the current first-line drug for the treatment of chronic obstructive pulmonary disease, tiotropium bromide, the quality of its inhalant products has an important impact on the clinical efficacy and safety.

Recently, the "Quality Evaluation of Tiotropium Bromide Inhalation Powder Mist from Different Manufacturers-Experimental Research Report" (hereinafter referred to as the "Report") carried out by Professor Sha Xianyi of the School of Pharmacy of Fudan University and others was published.The study compared the relevant substances and indicators of the characteristics of the inhalation powder mist of tiotropium bromide produced by different domestic and original research manufacturers, and aims to provide a reference and basis for clinical medication.